“Skin problems can really affect how people feel about themselves, and being able to help them regain confidence and comfort is incredibly rewarding.“
With a career that bridges continents and disciplines, we are delighted to feature Dr Yi-Kui Xiang in our touchDERMATOLOGY Future Leaders 2025 initiative. Based in Berlin, Germany, Dr Xiang serves as a clinical scientist at both the Charité Institute of Allergology and the Fraunhofer Institute for Immunology and Allergology, but also maintains a clinical role at the Shanghai Skin Disease Hospital in China. His research interests span from urticaria, IgE-mediated autoimmunity and allergology to alopecia, pruritus, psychodermatology, and patient-reported outcomes.
In this conversation, we sat down with Dr Xiang to learn what inspired him to enter the field, his most rewarding moment so far, and what excites him about the future of dermatology.
Dermatology attracted me because it combines visual diagnosis, hands-on procedures, and long-term patient care. Skin problems can really affect how people feel about themselves, and being able to help them regain confidence and comfort is incredibly rewarding for me.
A patient with a severe drug eruption once told me that my care helped her recover both physically and emotionally. Seeing his smile again after such a scary experience reminded me why I love this work.
I am excited by how digital tools are improving care, especially mobile apps that help measure patient-reported outcomes. They give real-time insight into symptoms and quality of life, making it easier to track progress and adjust treatments more precisely.
Disclosures: This short article was prepared by touchDERMATOLOGY in collaboration with Dr Xiang. No fees or funding were associated with its publication.
touchDERMATOLOGY is celebrating the brightest rising stars in the dermatology community, who are set to shape the future of the field.
Read more about the touchDERMATOLOGY Future Leaders 2025 here.
Register now to receive the touchDERMATOLOGY newsletter!
Don’t miss out on hearing about our latest articles, expert opinions, conference news, podcasts and more.
